Literature DB >> 30360782

The Pulmonary Endothelial Glycocalyx in ARDS: A Critical Role for Heparan Sulfate.

Wells B LaRivière1, Eric P Schmidt2.   

Abstract

The endothelial glycocalyx is a glycosaminoglycan-enriched endovascular layer that, with the development of novel fixation and in vivo microscopy techniques, has been increasingly recognized as a major contributor to vascular homeostasis. Sepsis-associated degradation of the endothelial glycocalyx mediates the onset of the alveolar microvascular dysfunction characteristic of sepsis-induced lung injury (such as the Acute Respiratory Distress Syndrome, ARDS). Emerging evidence indicates that processes of glycocalyx reconstitution are necessary for endothelial repair and, as such, are promising therapeutic targets to accelerate lung injury recovery. This review discusses what has been learned about the homeostatic and pathophysiologic role of the pulmonary endothelial glycocalyx during lung health and injury, with the goal to identify promising new areas for future mechanistic investigation.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelial surface layer; Glycocalyx; Glycosaminoglycan; Heparan sulfate; Lung injury; Proteoglycan; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 30360782     DOI: 10.1016/bs.ctm.2018.08.005

Source DB:  PubMed          Journal:  Curr Top Membr        ISSN: 1063-5823            Impact factor:   3.049


  18 in total

1.  Alveolar heparan sulfate shedding impedes recovery from bleomycin-induced lung injury.

Authors:  W B LaRivière; S Liao; S A McMurtry; K Oshima; X Han; F Zhang; S Yan; S M Haeger; M Ransom; J A Bastarache; R J Linhardt; E P Schmidt; Y Yang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-22       Impact factor: 5.464

Review 2.  Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.

Authors:  Nicolas Wiernsperger; Abdallah Al-Salameh; Bertrand Cariou; Jean-Daniel Lalau
Journal:  Diabetes Metab       Date:  2022-05-31       Impact factor: 8.254

Review 3.  Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19.

Authors:  Duoduo Zha; Mingui Fu; Yisong Qian
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

4.  Endothelial glycocalyx shedding in the acute respiratory distress syndrome after flu syndrome.

Authors:  Maira Nilson Benatti; Alexandre Todorovic Fabro; Carlos Henrique Miranda
Journal:  J Intensive Care       Date:  2020-09-21

5.  Endothelial glycocalyx degradation is associated with early organ impairment in polytrauma patients.

Authors:  Feng Qi; Hao Zhou; Peng Gu; Zhi-He Tang; Bao-Feng Zhu; Jian-Rong Chen; Jin-Song Zhang; Feng Li
Journal:  BMC Emerg Med       Date:  2021-04-20

Review 6.  On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx.

Authors:  Matthias Ochs; Jan Hegermann; Elena Lopez-Rodriguez; Sara Timm; Geraldine Nouailles; Jasmin Matuszak; Szandor Simmons; Martin Witzenrath; Wolfgang M Kuebler
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

7.  Alveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome.

Authors:  Jun Li; Zhijiang Qi; Dongxiao Li; Xiao Huang; Boyang Qi; Jiali Feng; Jianyu Qu; Xiaozhi Wang
Journal:  Biomed Pharmacother       Date:  2020-11-24       Impact factor: 6.529

8.  Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse.

Authors:  Tamara L Paget; Emma J Parkinson-Lawrence; Paul J Trim; Chiara Autilio; Madhuriben H Panchal; Grielof Koster; Mercedes Echaide; Marten F Snel; Anthony D Postle; Janna L Morrison; Jésus Pérez-Gil; Sandra Orgeig
Journal:  Cells       Date:  2021-04-08       Impact factor: 6.600

9.  Detection of Glycosaminoglycans by Polyacrylamide Gel Electrophoresis and Silver Staining.

Authors:  Wells B LaRiviere; Xiaorui Han; Kaori Oshima; Sarah A McMurtry; Robert J Linhardt; Eric P Schmidt
Journal:  J Vis Exp       Date:  2021-02-25       Impact factor: 1.424

10.  Increased Plasma Heparanase Activity in COVID-19 Patients.

Authors:  Baranca Buijsers; Cansu Yanginlar; Aline de Nooijer; Inge Grondman; Marissa L Maciej-Hulme; Inge Jonkman; Nico A F Janssen; Nils Rother; Mark de Graaf; Peter Pickkers; Matthijs Kox; Leo A B Joosten; Tom Nijenhuis; Mihai G Netea; Luuk Hilbrands; Frank L van de Veerdonk; Raphaël Duivenvoorden; Quirijn de Mast; Johan van der Vlag
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.